Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FW5TD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,675
Award facts
- Contract value 100% obligated
- $19,675.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $19,675.26 delivery order to AmerisourceBergen Drug Corp on June 17, 2026, for RINVOQ ER 30 mg tablets (30-count units). Place of performance is Conshohocken, PA. Ultimate completion date is June 18, 2026. The order carries firm fixed-price pricing and no set-aside.
Quick answers
Who was awarded contract SPE2DR26FW5TD?
SPE2DR26FW5TD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 17, 2026.
How much is contract SPE2DR26FW5TD worth?
The government has obligated $19,675 on SPE2DR26FW5TD.
Is contract SPE2DR26FW5TD an order under another contract?
Yes. SPE2DR26FW5TD is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW5TD competed?
The extent of competition for SPE2DR26FW5TD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award